Showing results (11-20 of 174) with videos related to
Sort By:
Pageof 18
British Medical Journal|June 28, 1975
Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatmentE C Johnstone, K WhaleyActa Psychiatrica Scandinavica. Supplementum|January 1, 1994
How high is the relapse rate in schizophrenia?E C Johnstone, J GeddesBritish Journal of Clinical Pharmacology|January 6, 2012
Acetylator phenotype and the clinical pharmacology of slow-release procainamideW Campbell, W J Tilstone, D H Lawson, et al.European Journal of Clinical Pharmacology|December 1, 1978
The pharmacokinetics of slow-release procainamideW J Tilstone, D H Lawson, W Campbell, et al.Postgraduate Medical Journal|July 1, 1977
Interaction between warfarin and sulphamethoxazoleW J Tilstone, J M Gray, R H Nimmo-Smith, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1981
Neurological changes in a population of patients with chronic schizophrenia and their relationship to physical treatmentE C Johnstone, D G OwensThe British Journal of Psychiatry : the Journal of Mental Science|October 1, 1981
A follow-up study of severe puerperal psychiatric illnessL da Silva, E C JohnstoneHealth Bulletin|June 19, 2003
Early-onset dementia in Lothian, Scotland: an analysis of clinical features and patterns of declineK J Woodburn, E C JohnstoneCurrent Psychiatry Reports|December 21, 2000
Should the treatment of schizophrenia include old antipsychotic drugs?R M Steel, E C JohnstonePsychological Medicine|July 1, 1996
Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patientsE C Johnstone, C D FrithPageof 18